Evolution of tumor metabolism might reflect carcinogenesis as a reverse evolution process (dismantling of multicellularity)

Cancers

Volumn 3, Issue 3, 2011, Pages 3002-3017

  Alfarouk, Khalid O ^a   Shayoub, Mohammed E A ^b   Muddathir, Abdel Khalig ^b   Elhassan, Gamal O ^c   Bashir, Adil H H ^a,d  

^a Hala Alfarouk Cancer Center   (Sudan)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c FEDERAL MINISTRY OF HEALTH   (Sudan)

^d Al Jawda Medical Hospital   (Sudan)

Author keywords

Cannibalism; Convergent evolution; Crabtree effect; Lactate symbiosis; Pasteur effect; Reverse evolution; Warburg effect

Indexed keywords

GLUCOSE; LACTIC ACID;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL METABOLISM; CITRIC ACID CYCLE; COLONY FORMATION; CONVERGENT EVOLUTION; ENDOSYMBIOSIS; ENERGY METABOLISM; GLYCOLYSIS; ILLNESS TRAJECTORY; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; OXIDATIVE STRESS; PHENOTYPIC VARIATION; TUMOR CELL; TUMOR MICROENVIRONMENT;

EID: 80053185587     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3033002     Document Type: Article

References (78)

1. Thomson, J.M.; Gaucher, E.A.; Burgan, M.F.; de Kee, D.W.; Li, T.; Aris, J.P.; Benner, S.A. Resurrecting ancestral alcohol dehydrogenases from yeast. Nat. Genet. 2005, 37, 630-635.
2. Alfarouk, K.O.; Muddathir, A.K.; Shayoub, M.E.A. Tumor acidity as evolutionary spite. Cancers 2011, 3, 408-414.
3. Sagan, L. On the origin of mitosing cells. J. Theor. Biol. 1967, 14, 255-274.
4. Liangpunsakul, S.; Sozio, M.S.; Shin, E.; Zhao, Z.; Xu, Y.; Ross, R.A.; Zeng, Y.; Crabb, D.W. Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298, G1004-G1012.
5. Jose, M.C.M.; Estefania, B.M.; Concepcion, P.G.; Javier, S.; Antonio, R.; Miguel, L.L. Role of the intracellular pH in the metabolic switch between oxidative phosphorylation and aerobic glycolysis-Relevance to cancer. Webmed Cent. Cancer 2011, 2, WMC001716.
6. Vaughn, A.E.; Deshmukh, M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat. Cell Biol. 2008, 10, 1477-1483.
7. Merlo, L.M.; Pepper, J.W.; Reid, B.J.; Maley, C.C. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 2006, 6, 924-935.
8. Crabtree, H.G. Observations on the carbohydrate metabolism of tumours. Biochem. J. 1929, 23, 536-545.
9. Diaz-Ruiz, R.; Uribe-Carvajal, S.; Devin, A.; Rigoulet, M. Tumor cell energy metabolism and its common features with yeast metabolism. Biochim. Biophys. Acta 2009, 1796, 252-265.
10. Diaz-Ruiz, R.; Rigoulet, M.; Devin, A. The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim. Biophys. Acta 2011, 1807, 568-576.
11. Williams, B.; Howard, R.L. Glucose-induced changes in Na+/H+ antiport activity and gene expression in cultured vascular smooth muscle cells. Role of protein kinase C. J. Clin. Invest. 1994, 93, 2623-2631.
12. Cardone, R.A.; Busco, G.; Greco, M.R.; Bellizzi, A.; Accardi, R.; Cafarelli, A.; Monterisi, S.; Carratù, P.; Casavola, V.; Paradiso, A.; et al. HPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha. PLoS One 2008, 3, e3529.
13. Reshkin, S.J.; Bellizzi, A.; Caldeira, S.; Albarani, V.; Malanchi, I.; Poignee, M.; Alunni-Fabbroni, M.; Casavola, V.; Tommasino, M. Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 2000, 14, 2185-2197.
14. Gatenby, R.A.; Smallbone, K.; Maini, P.K.; Rose, F.; Averill, J.; Nagle, R.B.; Worrall, L.; Gillies, R.J. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br. J. Cancer 2007, 97, 646-653.
15. Fang, J.S.; Gillies, R.D.; Gatenby, R.A. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin. Cancer Biol. 2007, 18, 330-337.
16. Alfarouk, K.O.; Bashir, A.H. Diabetes mellitus type 2 through oncology lens. Med. Hypotheses 2011, 76, 761-762.
17. Abbate, F.; Casini, A.; Owa, T.; Scozzafava, A.; Supuran, C.T. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 2004, 14, 217-223.
18. Genis, C.; Sippel, K.H.; Case, N.; Cao, W.; Avvaru, B.S.; Tartaglia, L.J.; Govindasamy, L.; Tu, C.; Agbandje-McKenna, M.; Silverman, D.N.; et al. Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties. Biochemistry 2009, 48, 1322-1331.
19. Teicher, B.A.; Liu, S.D.; Liu, J.T.; Holden, S.A.; Herman, T.S. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res. 1993, 13, 1549-1556.
20. Fais, S.; de Milito, A.; You, H.; Qin, W. Targeting vacuolar H+-ATPases as a new strategy against cancer. Cancer Res. 2007, 67, 10627-10630.
21. Huber, V.; de Milito, A.; Harguindey, S.; Reshkin, S.J.; Wahl, M.L.; Rauch, C.; Chiesi, A.; Pouysségur, J.; Gatenby, R.A.; Rivoltini, L.; et al. Proton dynamics in cancer. J. Transl. Med. 2010, 8, 57.
22. Robey, I.F.; Baggett, B.K.; Kirkpatrick, N.D.; Roe, D.J.; Dosescu, J.; Sloane, B.F.; Hashim, A.I.; Morse, D.L.; Raghunand, N.; Gatenby, R.A.; et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 2009, 69, 2260-2268.
23. Spugnini, E.P.; Citro, G.; Fais, S. Proton pump inhibitors as anti vacuolar-ATPases drugs: A novel anticancer strategy. J. Exp. Clin. Cancer Res. 2010, 29, 44.
24. Harguindey, S.; Orive, G.; Luis, P.J.; Paradiso, A.; Reshkin, S.J. The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biochim. Biophys. Acta 2005, 1756, 1-24.
25. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674.
26. Warburg, O. On the origin of cancer cells. Science 1965, 123, 309-314.
27. Gatenby, R.A.; Gillies, R.J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 2004, 4, 891-899.
28. Racker, E. History of the Pasteur effect and its pathobiology. Mol. Cell Biochem. 1974, 5, 17-23.
29. Wu, R.; Racker, E. Regulatory mechanisms in carbohydrate metabolism. IV. Pasteur effect and Crabtree effect in ascites tumor cells. J. Biol. Chem. 1959, 234, 1036-1041.
30. Fais, S. Cannibalism: A way to feed on metastatic tumors. Cancer Lett.2007, 258, 155-164.
31. Brahimi-Horn, M.C.; Bellot, G.; Pouysségur, J. Hypoxia and energetic tumour metabolism. Curr. Opin. Genet. Dev. 2011, 21, 67-72.
32. Chiche, J.; Brahimi-Horn, M.C.; Pouysségur, J. Tumour hypoxia induces a metabolic shift causing acidosis: A common feature in cancer. J. Cell Mol. Med. 2010, 14, 771-794.
33. Chiche, J.; Rouleau, M.; Gounon, P.; Brahimi-Horn, M.C.; Pouysségur, J.; Mazure, N.M. Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J. Cell Physiol. 2010, 222, 648-657.
34. Lozupone, F.; Perdicchio, M.; Brambilla, D.; Borghi, M.; Meschini, S.; Barca, S.; Marino, M.L.; Logozzi, M.; Federici, C.; Iessi, E.; et al. The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells. EMBO Rep. 2009, 10, 1348-1354.
35. Davies, P.C.; Lineweaver, C.H. Cancer tumors as Metazoa 1.0: Tapping genes of ancient ancestors. Phys. Biol. 2011, 8, 015001.
36. Gatenby, R.A.; Gillies, R.J.; Brown, J.S. Evolutionary dynamics of cancer prevention. Nat. Rev. Cancer 2010, 10, 526-527.
37. Gatenby, R.A.; Brown, J.S. Of cancer and cave fish. Nat. Rev. Cancer 2011, 11, 237-238.
38. Gatenby, R.A.; Frieden, B.R. Application of information theory and extreme physical information to carcinogenesis. Cancer Res. 2002, 62, 3675-3684.
39. Gatenby, R.A.; Frieden, B.R. Information dynamics in carcinogenesis and tumor growth. Mutat. Res. 2004, 568, 259-273.
40. Gatenby, R.A.; Frieden, B.R. Information theory in living systems, methods, applications, and challenges. Bull. Math. Biol. 2007, 69, 635-657.
41. Gatenby, R.A.; Vincent, T.L. An evolutionary model of carcinogenesis. Cancer Res. 2003, 63, 6212-6220.
42. Gatenby, R.A. Commentary: Carcinogenesis as Darwinian evolution? Do the math! Int. J. Epidemiol. 2006, 35, 1165-1167.
43. Sciamanna, I.; Vitullo, P.; Curatolo, A.; Spadafora, C. Retrotransposons, reverse transcriptase and the genesis of new genetic information. Gene 2009, 448, 180-186.
44. Qiao, D.; Zeeman, A.M.; Deng, W.; Looijenga, L.H.; Lin, H. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 2002, 21, 3988-3999.
45. Guppy, M.; Leedman, P.; Zu, X.; Russell, V. Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem. J. 2002, 364, 309-315.
46. Feron, O. Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother. Oncol. 2009, 92, 329-333.
47. Dang, C.V. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res. 2010, 70, 859-862.
48. Sonveaux, P.; Végran, F.; Schroeder, T.; Wergin, M.C.; Verrax, J.; Rabbani, Z.N.; de Saedeleer, C.J.; Kennedy, K.M.; Diepart, C.; et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 2008, 118, 3930-3940.
49. Philp, A.; Macdonald, A.L.; Watt, P.W. Lactate-A signal coordinating cell and systemic function. J. Exp. Biol. 2005, 208, 4561-4575.
50. Sola-Penna, M. Metabolic regulation by lactate. IUBMB Life 2008, 60, 605-608.
51. Parlo, R.A.; Coleman, P.S. Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria. The truncated Krebs cycle and other metabolic ramifications of mitochondrial membrane cholesterol. J. Biol. Chem. 1984, 259, 9997-10003.
52. Pavlides, S.; Whitaker-Menezes, D.; Castello-Cros, R.; Flomenberg, N.; Witkiewicz, A.K.; Frank, P.G.; Casimiro, M.C.; Wang, C.; Fortina, P.; Addya, S.; et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009, 8, 3984-4001.
53. Goss, P.E.; Chambers, A.F. Does tumour dormancy offer a therapeutic target? Nat. Rev. Cancer 2010, 10, 871-877.
54. Grillon, E.; Farion, R.; Fablet, K.; de Waard, M.; Tse, C.M.; Donowitz, M.; Rémy, C.; Coles, J.A. The spatial organization of proton and lactate transport in a rat brain tumor. PLoS One 2011, 6, e17416.
55. Vellai, T.; Vida, G. The origin of eukaryotes: The difference between prokaryotic and eukaryotic cells. Proc. Biol. Sci. 1999, 266, 1571-1577.
56. Lindmark, D.G.; Müller, M. Hydrogenosome, a cytoplasmic organelle of the anaerobic flagellate Tritrichomonas foetus, and its role in pyruvate metabolism. J. Biol. Chem. 1973, 248, 7724-7728.
57. Gabaldón, T.; Huynen, M.A. Shaping the mitochondrial proteome. Biochim. Biophys. Acta 2004, 1659, 212-220.
58. Gabaldón, T.; Huynen, M.A. From endosymbiont to host-controlled organelle: The hijacking of mitochondrial protein synthesis and metabolism. PLoS Comput. Biol. 2007, 3, e219.
59. Gray, M.W.; Burger, G.; Lang, B.F. Mitochondrial evolution. Science 1999, 283, 1476-1481.
60. De Duve, C. The origin of eukaryotes: A reappraisal. Nat. Rev. Genet. 2007, 8, 395-403.
61. Kurland, C.G.; Andersson, S.G. Origin and evolution of the mitochondrial proteome. Microbiol. Mol. Biol. Rev. 2000, 64, 786-820.
62. Hackstein, J.H.; Akhmanova, A.; Boxma, B.; Harhangi, H.R.; Voncken, F.G. Hydrogenosomes: Eukaryotic adaptations to anaerobic environments. Trends Microbiol. 1999, 7, 441-447.
63. Hackstein, J.H.; Akhmanova, A.; Voncken, F.; van Hoek, A.; van Alen, T.; Boxma, B.; Moon-van der Staay, S.Y.; van der Staay, G.; Leunissen, J.; Huynen, M.; et al. Hydrogenosomes: Convergent adaptations of mitochondria to anaerobic environments. Zoology (Jena) 2001, 104, 290-302.
64. Asquith, J.C.; Watts, M.E.; Patel, K.; Smithen, C.E.; Adams, G.E. Electron affinic sensitization: V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles. Radiat. Res. 1974, 60, 108-118.
65. Denekamp, J.; Michael, B.D.; Harris, S.R. Hypoxic cell radiosensitizers: Comparative tests of some electron affinic compounds using epidermal cell survival in vivo. Radiat. Res. 1974, 60, 119-132.
66. Eyre, H.J.; Ohlsen, J.D.; Frank, J.; LoBuglio, A.F.; McCracken, J.D.; Weatherall, T.J.; Mansfield, C.M. Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study. J. Neurooncol. 1984, 2, 325-330.
67. Hrdý, I.; Cammack, R.; Stopka, P.; Kulda, J.; Tachezy, J. Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes. Antimicrob. Agents Chemother. 2005, 49, 5033-5036.
68. Kulda, J. Trichomonads, hydrogenosomes and drug resistance. Int. J. Parasitol. 1999, 29, 199-212.
69. Polyakov, P.Y.; Daryalova, S.L.; Pelevina, I.I.; Karakulov, R.K.; Zeljvin, B.M.; Kiseleva, E.S.; Kvasov, V.A. Studies of metronidazole radiosensitizing effect in radiation treatment of patients with oral cavity cancer. Neoplasma 1985, 32, 103-111.
70. Rabin, H.R.; Urtasun, R.C.; Partington, J.; Koziol, D.; Sharon, M.; Walker, K. High-dose metronidazole: Pharmacokinetics and bioavailability using an iv preparation and application of its use as a radiosensitizer. Cancer Treat. Rep. 1980, 64, 1087-1095.
71. Higuchi, M. Regulation of mitochondrial DNA content and cancer. Mitochondrion 2007, 7, 53-57.
72. Akhmanova, A.; Voncken, F.; van Alen, T.; van Hoek, A.; Boxma, B.; Vogels, G.; Veenhuis, M.; Hackstein, J.H. A hydrogenosome with a genome. Nature 1998, 396, 527-528.
73. Boxma, B.; de Graaf, R.M.; van der Staay, G.W.; van Alen, T.A.; Ricard, G.; Gabaldón, T.; van Hoek, A.H.; Moon-van der Staay, S.Y.; Koopman, W.J.; van Hellemond, J.J. et al. An anaerobic mitochondrion that produces hydrogen. Nature 2005, 434, 74-79.
74. Sara, R.E.; Juan, C.G.P.; Alejandro, A.S.; Alvaro, M.H.; Liliana, C.F.; Vilma, M.L.; Rafael, M.S. Energy metabolism transition in multi-cellular human tumor spheroids. J. Cell Physiol. 2008, 216, 189-197.
75. Schwertz, H.; Köster, S.; Kahr, W.H.; Michetti, N.; Kraemer, B.F.; Weitz, D.A.; Blaylock, R.C.; Kraiss, L.W.; Greinacher, A.; Zimmerman, G.A. et al. Anucleate platelets generate progeny. Blood 2010, 115, 3801-3809.
76. Martin, N.K.; Gaffney, E.A.; Gatenby, R.A.; Maini, P.K. Tumour-stromal interactions in acid-mediated invasion: A mathematical model. J. Theor. Biol. 2010, 267, 461-470.
77. Hickson, J.; Diane Yamada S.; Berger J.; Alverdy J.; O'Keefe J.; Bassler B.; Rinker-Schaeffer C. Societal interactions in ovarian cancer metastasis: A quorum-sensing hypothesis. Clin Exp Metastasis. 2009, 26, 67-76.
78. Végran, F.; Boidot, R.; Michiels, C.; Sonveaux, P.; Feron, O. Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF-{kappa} B/IL-8 Pathway that Drives Tumor Angiogenesis. Cancer Res. 2011, 71, 2550-60.